Jiasi Zhang[Author] - Search Results

Year	Number of Results
2002	1
2018	1
2019	2
2020	2
2021	9
2022	9
2023	8
2024	1

1

Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides.

Bonté PE, Arribas YA, Merlotti A, Carrascal M, Zhang JV, Zueva E, Binder ZA, Alanio C, Goudot C, Amigorena S. Bonté PE, et al. Among authors: zhang jv. Cell Rep. 2022 Jun 7;39(10):110916. doi: 10.1016/j.celrep.2022.110916. Cell Rep. 2022. PMID: 35675780 Free article.

2

FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m⁶A-YTHDF2-dependent manner.

Xu A, Zhang J, Zuo L, Yan H, Chen L, Zhao F, Fan F, Xu J, Zhang B, Zhang Y, Yin X, Cheng Q, Gao S, Deng J, Mei H, Huang Z, Sun C, Hu Y. Xu A, et al. Among authors: zhang j. Mol Ther. 2022 Mar 2;30(3):1104-1118. doi: 10.1016/j.ymthe.2021.12.012. Epub 2021 Dec 13. Mol Ther. 2022. PMID: 34915192 Free PMC article.

3

Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors.

Yin Y, Rodriguez JL, Li N, Thokala R, Nasrallah MP, Hu L, Zhang L, Zhang JV, Logun MT, Kainth D, Haddad L, Zhao Y, Wu T, Johns EX, Long Y, Liang H, Qi J, Zhang X, Binder ZA, Lin Z, O'Rourke DM. Yin Y, et al. Among authors: zhang jv. Mol Ther. 2022 Jul 6;30(7):2537-2553. doi: 10.1016/j.ymthe.2022.05.011. Epub 2022 May 14. Mol Ther. 2022. PMID: 35570396 Free PMC article.

4

XBP1 modulates endoplasmic reticulum and mitochondria crosstalk via regulating NLRP3 in renal ischemia/reperfusion injury.

Ni H, Ou Z, Wang Y, Liu Y, Sun K, Zhang J, Zhang J, Deng W, Zeng W, Xia R, Xu J, Gong N, Miao Y. Ni H, et al. Among authors: zhang j. Cell Death Discov. 2023 Feb 17;9(1):69. doi: 10.1038/s41420-023-01360-x. Cell Death Discov. 2023. PMID: 36801911 Free PMC article.

5

MALAT1 regulates network of microRNA-15a/16-VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma.

Yan H, Gao S, Xu A, Zuo L, Zhang J, Zhao Y, Cheng Q, Yin X, Sun C, Hu Y. Yan H, et al. Among authors: zhang j. Carcinogenesis. 2023 Dec 15;44(10-11):760-772. doi: 10.1093/carcin/bgad053. Carcinogenesis. 2023. PMID: 37549238

6

Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T.

Shiqi L, Jiasi Z, Lvzhe C, Huailong X, Liping H, Lin L, Qianzhen Z, Zhongtao Y, Junjie S, Zucong C, Yingzi Z, Meiling W, Yunyan L, Linling W, Lihua F, Yingnian C, Wei Z, Yu L, Le L, Youcheng W, Dingsong Z, Yancheng D, Ping Y, Lihua Z, Xiaoping L, Xiaozhuang H, Zhongzheng Z, Zhi Y, Cheng Q, Sanbin W. Shiqi L, et al. Among authors: jiasi z. Mol Ther Oncolytics. 2023 Apr 20;29:107-117. doi: 10.1016/j.omto.2023.04.003. eCollection 2023 Jun 15. Mol Ther Oncolytics. 2023. PMID: 37215385 Free PMC article.

7

ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis.

Zhang J, Liu Y, Li Q, Zuo L, Zhang B, Zhao F, Fan F, Luo S, Hu Y, Sun C. Zhang J, et al. Carcinogenesis. 2023 May 27;44(3):242-251. doi: 10.1093/carcin/bgad015. Carcinogenesis. 2023. PMID: 36999754

8

Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism.

Zhang J, Liu Y, Li Q, Xu A, Hu Y, Sun C. Zhang J, et al. Biomed Pharmacother. 2022 Apr;148:112747. doi: 10.1016/j.biopha.2022.112747. Epub 2022 Feb 28. Biomed Pharmacother. 2022. PMID: 35240523 Free article. Review.

9

Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosis.

Guan T, Zhou T, Zhang X, Guo Y, Yang C, Lin J, Zhang JV, Cheng Y, Marzban H, Wang YT, Kong J. Guan T, et al. Among authors: zhang jv. Cell Mol Life Sci. 2023 Sep 26;80(10):304. doi: 10.1007/s00018-023-04956-9. Cell Mol Life Sci. 2023. PMID: 37752364

10

Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes.

Alanio C, Binder ZA, Chang RB, Nasrallah MP, Delman D, Li JH, Tang OY, Zhang LY, Zhang JV, Wherry EJ, O'Rourke DM, Beatty GL. Alanio C, et al. Among authors: zhang jv. Cancer Immunol Res. 2022 Jul 1;10(7):800-810. doi: 10.1158/2326-6066.CIR-21-1050. Cancer Immunol Res. 2022. PMID: 35507919 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year